Neubond secures £286.8k seed funding for neuro-rehabilitation wearable

A wearable device designed to help stroke patients regain movement is at the center of a £286.8k seed funding round for Neubond Ltd. The London-based company, incorporated in 2024, develops neuro-rehabilitation technology for individuals with mobility impairments.

The hardware utilizes integrated muscle sensors and stimulators that detect a user's intention to move. By delivering precise feedback, the system aims to strengthen brain-muscle connections and accelerate the recovery process. These personalized devices are intended for home use, allowing users to integrate therapy into their daily routines.

Financial filings from June 2026 confirm the allotment of shares for this round. According to accounts for the year ended 28 February 2026, the business employed four people. However, more recent data from LinkedIn indicates the team has since expanded to 12 employees. The company operates within the medical equipment manufacturing sector, focusing on establishing a direct connection to the patient's body.